Advancing gene therapy has the potential to fundamentally change the way we treat bleeding disorders. This #WorldHemophiliaDay, we’re highlighting the science and clinical progress moving the field toward a future of durable, long-term care.
Read more: https://bit.ly/41RyslL
Congratulations to Rachel Salzman, DVM, recipient of the 2026 ASGCT Exemplary Service Award! Meet all of this year's award recipients: https://bit.ly/3MLe5T
Now available on demand in the ASGCT Learning Center, this free, one-hour session features expert insights into the development of oncolytic adenovirus series and innovative AAV strategies for treating lysosomal storage disorders: https://learning.asgct.org/courses/171745
The BIO-ASGCT CGT Science Series is back! The latest session dove into advanced analytical approaches for rAAV characterization, including genome/capsid analysis and standardization efforts. Check out The Advocate for more details: https://bit.ly/3OCZLxd
#ASGCTAdvocacy
Headed to Boston for #ASGCT2026? Rooms are limited and filling up fast! Secure the discounted group rate and stay close to all the action: annualmeeting.asgct.org/register-attend/travel-a...
Host Emily Walsh Martin catches up with Amber Freed, founder of SLC6A1 Connect, for a powerful look at the caregiver’s journey. Amber shares an update on her son Maxwell’s treatment for SLC6A1 and the critical role advocacy plays in the path toward a cure.
🎧 Listen: https://bit.ly/4tgvXpe
Today is #WorldParkinsonsDay, a time to raise awareness and support for the millions of people living with Parkinson's worldwide. Explore our free patient education resources to learn more about the latest progress in cell and gene therapy for Parkinson's disease: https://bit.ly/3Q6fa9C
Congratulations to Denise Gavin, Ph.D., recipient of the 2026 ASGCT Sonia Skarlatos Public Service Award! Join us in celebrating her dedicated public service at #ASGCT2026.
Read more: www.asgct.org/news-publications/asgct-...
Is your expertise keeping pace? We've just expanded our free Foundations of CGT course with two specialized modules: Clinical Management and Manufacturing Challenges.
🆓 Start learning: https://bit.ly/4tmnsIK
Join Kelvin H. Lee, PhD, and Chris Williams as they discuss measuring vector genome titers, capsid content, and collaborative efforts to improve analytical standardization across the field.
Watch the webinar on demand for free: https://bit.ly/4so6o49
TODAY! Register to watch live or on demand: www.asgct.org/events-meeti...
3 new collections just dropped! Get tips on grant writing, dive into genome editing, and grow your manuscript writing and journal strategy skills.
Free for ASGCT members! Check it out: asgct.org/learning
Join #ASGCT2026 virtually to access the year’s most anticipated CGT program! Whether you’re tuning in live or catching up on-demand, stay connected to the innovations moving our field forward – no travel required.
Register today: https://annualmeeting.asgct.org/register-attend
The FDA has granted accelerated approval to Kresladi, the first gene therapy for pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I). Read more: www.fda.gov/news-events/press-announ...
There is still time to register! Explore the complex interplay between advanced nanotechnology and biomedical innovation, focusing on the transformative potential of LNPs in developing precise and effective therapeutic interventions.
Join us this Wednesday at 10 a.m. CT: https://bit.ly/3MJ6RiV
ASGCT is excited to share our first-ever Impact Report, recapping our Society’s activities in 2025. We invite you to dive into our 2025 Impact Report to learn more: asgct.org/impact
How do you stay calm under the industry’s toughest scrutiny? Emily Walsh Martin and Dr. Ralph Brandenberger (Dark Horse Consulting) peel back the curtain on the due diligence process for funding, partnerships, and acquisitions.
🎧 Listen to the new episode of The Issue: https://bit.ly/4ssxlEe
Check your inbox! 📥 This year, we received a record-breaking number of submissions, and the quality of research was truly exceptional. We can’t wait to see this groundbreaking science take center stage in Boston this May!
📣 Last call! Submit your groundbreaking, high-impact research for a chance to present at #ASGCT2026: annualmeeting.asgct.org/abstracts/submission-inf...
For #RareDiseaseDay, ASGCT submitted testimony to the Senate Aging Committee urging regulatory approaches that align with modern science, including flexibility for single-arm trials, external controls & platform-based #CGT development. Read more: https://bit.ly/4cWioWT
Explore the complex interplay between advanced nanotechnology and biomedical innovation, focusing on the transformative potential of LNPs in developing precise and effective therapeutic interventions in this free webinar.
Join us March 25 at 10 a.m. CT: https://bit.ly/3MJ6RiV
Exciting new addition to the Empowering Patients Summit! 📢 Join us for a live Q&A with ASGCT CEO David Barrett as he dives into the Society’s newest initiatives. Register for the free virtual Summit (March 11–12 and on demand): asgct.org/empowering
Congrats to Danaher Corporation, @ahrensnicklas.bsky.social, @kiranmusunuru.bsky.social, and @urnov.bsky.social! This group has been awarded the 2026 Catalyst Award for the extraordinary collaborative effort behind a first-of-its-kind personalized CRISPR gene-editing therapy: https://bit.ly/3MLe5Tt
Two new expert-led Content Collections are now live in the ASGCT Learning Center. Master the art of communication with The Scientist’s Writing Toolkit or deepen your technical knowledge with our Viral Vectors collection.
Free for ASGCT members! Start learning today: https://learning.asgct.org/
The February edition of The Patient Press is here! 🦓 From showing our stripes on #RareDiseaseDay to major policy wins like the PRV program reauthorization, we’re honoring the milestones that move the needle for patients: https://bit.ly/3MUvbON
Meet the winners of the 2026 ASGCT Honorific Awards! This year, we are thrilled to recognize 17 distinguished leaders who are making a profound impact to advance the field of cell and gene therapy.
Read the full announcement and learn more about our winners: https://bit.ly/4aQZi1C
Join our upcoming regulatory webinar to de-risk your PPQ campaign. We’re breaking down how to identify common gaps, mitigate risks, and build a clear roadmap for high-quality CGT production: www.asgct.org/events-meetings/ppq-read...
The 2026 #NORDSymposium takes place April 14-15, 2026 in Arlington, VA. This event connects
scientific and medical patient advocacy leaders with clinicians and researchers across rare diseases
to support research readiness, trial design, and progress for patients. https://nordscience.org/
Take your expertise to the next level with the ASGCT Learning Center! From engaging coursework to expert-led content collections, we have resources for every stage of your CGT career.
💻 Start learning: www.asgct.org/education-career-resourc...
ASGCT recently submitted comments to the OSTP highlighting the need for robust NIH funding, flexible CMC pathways, and improved public-private collaboration to advance cell and gene therapies.
Read our full policy recommendations: https://bit.ly/3OoVBIS
